{
  "docId": "019dd923-622c-750b-8b98-17b017c6aac8",
  "docSlug": "384ff8288d23",
  "documentTitle": "Acutus Medical Inc. (AFIB)",
  "authorId": "53_Kerrisdale_Capital",
  "authorName": "Kerrisdale Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 23,
  "pageCount": 29,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "other",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "This is a standard text-heavy page from a research report rather than a presentation slide.",
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-17b017c6aac8/23",
  "deckHref": "/decks/019dd923-622c-750b-8b98-17b017c6aac8",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-17b017c6aac8.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-17b017c6aac8#slide-23",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Acutus's PFA program, if successful, would be synergistically combined with the only mapping catheter capable of advanced diagnostics of complex arrhythmias.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-fb8f-761b-afcd-9f3a6f011e66",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.78,
        "x": 0.11,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "Kerrisdale Capital Management, LLC | 1212 Avenue of the Americas, 3rd Floor | New York, NY 10036 | Tel: 212.792.7999 | Fax: 212.531.6153",
      "attrs": null,
      "subkind": "disclaimer",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "426d91d1-31d3-43b8-9397-6c76444cc34e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "image",
      "text": "Kerrisdale Capital",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b6764d8-4670-46e5-80b8-75ea80ea8dfd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.77,
        "x": 0.11,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "But that gap will soon be filled. Acutus recently began enrolling patients in an IDE trial in the US that is designed to verify the safety of its AcQBlate contact-force catheter. Given the full CE-mark approval the device already secured in Europe at the end of last year, we expect full device approval by the end of 2022, or early 2023 at the latest.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c5adaaa-53ab-479a-b7ad-7e9949053a7b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.77,
        "x": 0.11,
        "y": 0.32
      },
      "kind": "paragraph",
      "text": "If that weren't enough, Acutus is also in the process of developing its own in-house pulsed field ablation (PFA) technology. We have discussed PFA previously as another game-changing technology in the field of ablation, which will allow extremely rapid and safe ablation through the power of electroporation rather than either RF or cryo...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d8391ac-eb87-40a7-9df4-473f38b3648e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.77,
        "x": 0.11,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "consumed in each ablation procedure, putting the total addressable market in Europe at about $2-2.5 billion. In total, we estimate Acutus's current TAM to be in the $3-4 billion range, with the lack of an ablation catheter line in the US the only major gap in its product portfolio.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5633ad8-2a61-4ec3-b39a-4338b5ed947f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.19,
        "w": 0.77,
        "x": 0.11,
        "y": 0.57
      },
      "kind": "paragraph",
      "text": "Acutus has recently said that it expects first-in-man studies of its PFA technology later this year, and the enrollment of an IDE trial next year. Acutus's focus on PFA technology within the specific context of persistent AF ablation would put it in the unique position of having not just the most complete ablation product line...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ddcd2947-f7ab-4cf3-ac59-f36364b37cde",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.77,
        "x": 0.11,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "The number of ablation procedures in that market has been growing rapidly, doubling over the last five years. We expect that the mid-teens growth rate of ablations will accelerate over the next five years. First, new technologies, including AcQMap but also the commercialization of pulsed field ablation (PFA), will help reduce the current procedure times...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8b38951-9435-4727-97c1-4a5697e65481",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}